intermediateinformed consentolanzapinemetabolic syndromeantipsychoticspatient autonomy
A PMHNP is initiating olanzapine for a 34-year-old man with schizophrenia who has failed two prior antipsychotic trials. The patient has a BMI of 29, a family history of type 2 diabetes, and a fasting glucose of 98 mg/dL. When discussing the medication, the patient states, 'Just give me whatever works — I trust you.' Which of the following best represents appropriate informed consent practice in this situation?